Seven warning signs of pancreatic cancer you shouldn't ignore as these subtle symptoms often get dismissed but could save ...

Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

Pancreatic cancer is the third-leading cause of death from cancer in the United States, after lung and colorectal cancers, according to the National Cancer Institute.

FDA approves expanded uses for immunotherapy 03:24 "With pancreatic cancer, it's a little bit of a Catch-22. That also is part of its challenge for clinicians and scientists who study it.

Pancreatic cancer occurs when malignant (cancerous) cells form in the pancreas, an organ located between the stomach and the spine, deep within the abdomen. Though relatively rare, pancreatic ...

Pancreatic cancer is limited to the pancreas, but has grown to less than 2 centimeters across (stage IA) or greater than 2 but no more than 4 centimeters (stage IB). Stage II: Local spread.

Pancreatic cancer can be challenging to diagnose early because it usually doesn't have any symptoms until it has grown large enough to affect your other digestive organs or spread outside your ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Metastatic pancreatic ductal adenocarcinoma, the most common and deadly form of pancreatic cancer, is seen here. Getty Images/iStockphoto. PAC-MANN was created using blood samples from 350 ...

A cycle ride will take place next week in memory of a keen Sheffield rider who died of pancreatic cancer. Aiden Batchelor ...